NASDAQ Companies

BOSTON, May 14, 2024 (GLOBE NEWSWIRE) —  Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based [...]

ANN ARBOR, Mich., May 14, 2024 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced today that the U.S. Patent and Trademark […]

SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]

LITTLETON, Colo., May 14, 2024 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical […]

BETHESDA, Md., May 14, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology […]

Omaha, May 14, 2024 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative […]

Potential to alleviate unmet need associated with depressed mood and anhedonia in bipolar depression; navacaprant has demonstrated the ability to […]

Updated interim data from the upliFT-D trial in FTD-GRN demonstrated that Dose 1 PBFT02 achieved consistent elevation of CSF progranulin […]

EATONTOWN, N.J., May 14, 2024 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary […]

Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June […]